Atlas Trials

Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL

Clinical trial NCT00772668 · TERMINATED

Trial details

NCT number
NCT00772668
Sponsor
University of Miami
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
LymphomaFollicular LymphomaMarginal Zone Lymphoma
Start date
2009-09-25
Primary completion
2010-12-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.